Project Profile

Cytokine and Inflammatory Mediator Measurements A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Intravenous FDY-5301 for the Prevention and Treatment of ICU Acquired Weakness in Major Trauma Patients

Keyword Search